Semiconductors Healthcare Sector

EyePoint Pharmaceuticals

Market Cap: US$377.4m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

AngioDynamics

Market Cap: US$377.2m

A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.

CytomX Therapeutics

Market Cap: US$375.0m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Faron Pharmaceuticals Oy

Market Cap: UK£280.4m

Operates as a clinical stage drug discovery and development company.

MeiraGTx Holdings

Market Cap: US$372.5m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

Prothena

Market Cap: US$370.6m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Mereo BioPharma Group

Market Cap: US$367.3m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Semler Scientific

Market Cap: US$362.9m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Erasca

Market Cap: US$359.8m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

TruBridge

Market Cap: US$359.4m

Provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.

COMPASS Pathways

Market Cap: US$358.4m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

Nano-X Imaging

Market Cap: US$357.7m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

NIOX Group

Market Cap: UK£267.7m

Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.

Oruka Therapeutics

Market Cap: US$354.2m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Myriad Genetics

Market Cap: US$354.0m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

Rapport Therapeutics

Market Cap: US$351.5m

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Capricor Therapeutics

Market Cap: US$350.3m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Alpha Teknova

Market Cap: US$348.4m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

SBC Medical Group Holdings

Market Cap: US$348.1m

Engages in the provision of management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally.

ClearPoint Neuro

Market Cap: US$347.8m

Operates as a medical device company primarily in the United States.

Checkpoint Therapeutics

Market Cap: US$347.6m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

Clinuvel Pharmaceuticals

Market Cap: AU$541.6m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Benitec Biopharma

Market Cap: US$346.2m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Cytek Biosciences

Market Cap: US$345.8m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

MBX Biosciences

Market Cap: US$339.9m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

TurnKey Capital

Market Cap: US$338.5m

HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.

ORIC Pharmaceuticals

Market Cap: US$337.0m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Pacific Biosciences of California

Market Cap: US$330.1m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

SNDL

Market Cap: US$329.3m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

Outset Medical

Market Cap: US$327.4m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

Rigel Pharmaceuticals

Market Cap: US$326.7m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Autolus Therapeutics

Market Cap: US$324.7m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Cryoport

Market Cap: US$324.4m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Mayne Pharma Group

Market Cap: AU$503.7m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

XOMA Royalty

Market Cap: US$320.0m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Cresco Labs

Market Cap: CA$435.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.